Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Vitamin d and pancreatic cancer-an update.

Chiang KC, Yeh CN, Chen TC.

Cancers (Basel). 2011 Jan 6;3(1):213-26. doi: 10.3390/cancers3010213.

2.

Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.

Stolzenberg-Solomon RZ, Schairer C, Moore S, Hollenbeck A, Silverman DT.

Am J Clin Nutr. 2013 Oct;98(4):1057-65. doi: 10.3945/ajcn.113.058123. Epub 2013 Aug 28.

3.

Dual origin, development, and fate of bovine pancreatic islets.

Merkwitz C, Lochhead P, Böttger J, Matz-Soja M, Sakurai M, Gebhardt R, Ricken AM.

J Anat. 2013 Mar;222(3):358-71. doi: 10.1111/joa.12014. Epub 2012 Nov 21.

4.

Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis.

Waraya M, Yamashita K, Katoh H, Ooki A, Kawamata H, Nishimiya H, Nakamura K, Ema A, Watanabe M.

BMC Cancer. 2012 Sep 7;12:397. doi: 10.1186/1471-2407-12-397.

5.

The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Wittel UA, Momi N, Seifert G, Wiech T, Hopt UT, Batra SK.

Int J Oncol. 2012 Jul;41(1):5-14. doi: 10.3892/ijo.2012.1414. Epub 2012 Mar 23. Review.

6.

Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota.

Prizment AE, Gross M, Rasmussen-Torvik L, Peacock JM, Anderson KE.

Pancreas. 2012 Jan;41(1):50-3. doi: 10.1097/MPA.0b013e3182247625.

7.

Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells.

Gupta S, Sathishkumar S, Ahmed MM.

Pancreatology. 2010;10(5):565-79. doi: 10.1159/000317254. Epub 2010 Oct 29.

8.

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch-Jacquotte A, Zheng W, Albanes D, Cai Q, Harvey C, Hayes R, Clipp S, Horst RL, Irish L, Koenig K, Le Marchand L, Kolonel LN.

Am J Epidemiol. 2010 Jul 1;172(1):81-93. doi: 10.1093/aje/kwq120. Epub 2010 Jun 18.

9.

Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study.

Mueller NT, Odegaard A, Anderson K, Yuan JM, Gross M, Koh WP, Pereira MA.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):447-55. doi: 10.1158/1055-9965.EPI-09-0862.

10.

Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study.

Chan JM, Wang F, Holly EA.

Cancer Causes Control. 2009 Aug;20(6):835-46. doi: 10.1007/s10552-009-9323-1. Epub 2009 Mar 11.

11.

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.

Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT.

Cancer Res. 2009 Feb 15;69(4):1439-47. doi: 10.1158/0008-5472.CAN-08-2694. Epub 2009 Feb 10.

12.

Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.

Stolzenberg-Solomon RZ, Weinstein S, Pollak M, Tao Y, Taylor PR, Virtamo J, Albanes D.

Am J Epidemiol. 2008 Nov 1;168(9):1047-55. doi: 10.1093/aje/kwn221. Epub 2008 Sep 18.

13.

Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States).

Luo J, Margolis KL, Adami HO, LaCroix A, Ye W; Women's Health Initiative Investigators..

Br J Cancer. 2008 Aug 5;99(3):527-31. doi: 10.1038/sj.bjc.6604487. Epub 2008 Jul 15.

14.

Vitamin D and pancreatic cancer.

Stolzenberg-Solomon RZ.

Ann Epidemiol. 2009 Feb;19(2):89-95. doi: 10.1016/j.annepidem.2008.03.010. Epub 2008 May 27. Review.

15.

Reproductive factors and pancreatic cancer risk: a Norwegian cohort study.

Heuch I, Jacobsen BK, Albrektsen G, Kvåle G.

Br J Cancer. 2008 Jan 15;98(1):189-93. Epub 2007 Nov 13.

16.

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.

Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS.

Br J Cancer. 2007 Jul 2;97(1):98-104. Epub 2007 May 29.

Supplemental Content

Support Center